It has subsequently been extended to incorporate the effects of rare pathogenic variants in the other established breast cancer susceptibility genes (PALB2, CHEK2 and ATM), the effects of several lifestyle/hormonal and reproductive risk factors, mammographic density and the latest validated PRS for breast cancer [12,26,41]. This evidence concerns the gene CHEK2 and breast cancer.